Stay updated on Radiation and Gene Therapy Clinical Trial
Sign up to get notified when there's something new on the Radiation and Gene Therapy Clinical Trial page.
Latest updates to the Radiation and Gene Therapy Clinical Trial page
- ChecktodayChange DetectedThe ENSIGN study record is displayed, describing a terminated Phase II trial of gene therapy and radiation followed by nivolumab for metastatic lung cancer and uveal melanoma. It includes eligibility criteria, treatment and outcome details, and links to study documents and participant-data sharing information.SummaryDifference61%
- Check7 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%
- Check14 days agoChange DetectedA banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence”.SummaryDifference1%
- Check21 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%
- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%
- Check49 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error page, replacing the usual content with an error screen. The detailed study information and related navigation are not accessible in this state.SummaryDifference20%
Stay in the know with updates to Radiation and Gene Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation and Gene Therapy Clinical Trial page.